Title: Gallium compound GaQ(3) -induced Ca(2+) signalling triggers p53-dependent and -independent apoptosis in cancer cells.
Journal: British journal of pharmacology 20120501
Title: Determination of gallium originated from a gallium-based anticancer drug in human urine using ICP-MS.
Journal: Analytical and bioanalytical chemistry 20110501
Title: The gallium complex KP46 exerts strong activity against primary explanted melanoma cells and induces apoptosis in melanoma cell lines.
Journal: Melanoma research 20091001
Title: The serum protein binding of pharmacologically active gallium(III) compounds assessed by hyphenated CE-MS techniques.
Journal: Electrophoresis 20090801
Title: Advances in developing tris(8-quinolinolato)gallium(iii) as an anticancer drug: critical appraisal and prospects.
Journal: Metallomics : integrated biometal science 20090101
Title: Capillary electrophoretic assay for the stability of tris(8-quinolinolato)gallium(III) in tablet formulations.
Journal: Journal of pharmaceutical and biomedical analysis 20080910
Title: Organic nanowire-templated fabrication of alumina nanotubes by atomic layer deposition.
Journal: Nano letters 20070601
Title: Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors--a CESAR study (Central European Society for Anticancer Drug Research--EWIV).
Journal: International journal of clinical pharmacology and therapeutics 20051201
